Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Pharmacological Research|December 18, 2019
Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalkYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Molecular Neurobiology|November 11, 2020
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
International Journal of Molecular Sciences|July 3, 2020
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic OpportunitiesYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Frontiers in Neurology|February 21, 2025
Blood-based biomarkers in mild behavioral impairment: an updated overviewEfthalia Angelopoulou, Xenia Androni, Chiara Villa, et al.
ACS Chemical Neuroscience|February 1, 2023
Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded ReviewEnes Akyuz, Betul Rana Celik, Feyza Sule Aslan, et al.
Biology|April 29, 2020
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading PathologyEfthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Pharmacological Research|April 12, 2020
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical resultsYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Biology|June 18, 2020
Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and TauYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Life Sciences|October 14, 2019
High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potentialYam Nath Paudel, Efthalia Angelopoulou, Bhuvan K C, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Mild Behavioral Impairment in Parkinson's Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological AspectsEfthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, et al.
Pageof 11